{"SPADE_N_06535": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_06535", "Peptide Name": "LvHemB1", "Source": "Litopenaeus vannamei", "Family": "", "Gene": "Not found", "Sequence": "DVNFLLHKIYGNIRY", "Sequence Length": 15, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:EC109 (49.01% decrease=50μg/mL); HepG2  (53.26% decrease=50μg/mL); HeLa (70.30% decrease=50μg/mL); EJ (78.44% decrease=50μg/mL)", "Hemolytic Activity": "Not available", "Cytotoxicity": "THLE-3:30.83% decrease=50μg/mL", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C88H133N23O22", "Mass": 1865.14, "PI": 8.5, "Net Charge": 2, "Hydrophobicity": -0.1, "Half Life": "Mammalian:1.1 hourYeast:3 minE.coli:>10 hour", "Literature": [{"Title": "LvHemB1, a novel cationic antimicrobial peptide derived from the hemocyanin of Litopenaeus vannamei, induces cancer cell death by targeting mitochondrial voltage-dependent anion channel 1", "Pubmed ID": "33630204", "Reference": "Cell Biol Toxicol. 2022 Feb;38(1)87-110.", "Author": "Liu S, Aweya JJ, Zheng L, Zheng Z, Huang H, Wang F, Yao D, Ou T, Zhang Y.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=33630204"}], "Frequent Amino Acids": "ILN", "Absent Amino Acids": "ACEMOPQSTUW", "Basic Residues": 3, "Acidic Residues": 1, "Hydrophobic Residues": 8, "Polar Residues": 8, "Positive Residues": 3, "Negative Residues": 1, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_19922", "Similarity": 1.0, "Sequence": "VNFLLHKIYGNIRYS"}, {"SPADE_ID": "SPADE_N_12312", "Similarity": 0.9285714285714286, "Sequence": "VNFLLHKIYDNIRYS"}, {"SPADE_ID": "SPADE_N_12313", "Similarity": 0.9285714285714286, "Sequence": "VNFLLHKIYGNIRDS"}]}}}